Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaoxue Zhu, Min Wu, Hong Wang, Haijun Li, Junjie Lin, Yun Peng, Yue Hu, Cuiyun Li & Yanhua Ding. (2021) Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study. Expert Opinion on Investigational Drugs 30:5, pages 579-589.
Read now
Read now
Jesús Recio Iglesias, Jesús Díez-Manglano, Francisco López García, José Antonio Díaz Peromingo, Pere Almagro & José Manuel Varela Aguilar. (2020) Management of the COPD Patient with Comorbidities: An Experts Recommendation Document. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1015-1037.
Read now
Read now
Articles from other publishers (19)
Mahmoud A. Desouky, Mina Y. George, Haidy E. Michel & Doaa A. Elsherbiny. (2023) Roflumilast escalates α-synuclein aggregate degradation in rotenone-induced Parkinson's disease in rats: Modulation of the ubiquitin-proteasome system and endoplasmic reticulum stress. Chemico-Biological Interactions 379, pages 110491.
Crossref
Crossref
Yuanzi Xu. (2022) The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease. The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease.
Hidehisa Saeki, Tomomi Imamura, Daisuke Yokota & Hidetsugu Tsubouchi. (2022) Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study. Dermatology and Therapy 12:7, pages 1589-1601.
Crossref
Crossref
Vítor S. Fernandes, María Elvira López-Oliva, María Pilar Martínez, Ángel Agis-Torres, Paz Recio, Jorge Navarro-Dorado, María Victoria Barahona, Sara Benedito, Dolores Prieto, Belén Climent & Medardo Hernández. (2022) In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters. Life Sciences 296, pages 120432.
Crossref
Crossref
Mitsugi Ookawara & Yasunori Nio. (2022) Phosphodiesterase 4 inhibitors in diabetic nephropathy. Cellular Signalling 90, pages 110185.
Crossref
Crossref
Hang-yu Chen, Xiao-xiao Li, Chao Li, Hai-chuan Zhu, Hong-yan Hou, Bo Zhang, Li-ming Cheng, Hui Hu, Zhong-xin Lu, Jia-xing Liu, Ze-ruo Yang, Lei Zhang, Nuo Xu, Long Chen, Chuan He, Chao-ran Dong, Qing-gang Ge & Jian Lin. (2022) 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Early Warning Biomarkers for COVID-19 Progression and Myocardial Injury. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Mohammad A. M. Momin, Bishal Raj Adhikari, Shubhra Sinha, Ian Larson & Shyamal C. Das. (2021) Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization. Pharmaceutics 13:8, pages 1254.
Crossref
Crossref
O. V. Zhukova & A. L. Khokhlov. (2020) Analysis of the long-term effectiveness of a drug in the treatment of a chronic disease is the basis of rational pharmacotherapy (on the example of the use of roflumilast in the treatment of chronic obstructive pulmonary disease). Kachestvennaya klinicheskaya praktika:3, pages 35-39.
Crossref
Crossref
Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard & Jens-Ulrik Stæhr Jensen. (2020) Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations. Journal of Clinical Medicine 9:5, pages 1442.
Crossref
Crossref
Sadia Janjua, Rebecca Fortescue & Phillippa Poole. (2020) Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2020:5.
Crossref
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2019) Treatment with inhaled α1-antitrypsin: a square peg in a round hole?. European Respiratory Journal 54:5, pages 1901894.
Crossref
Crossref
Amy E. Dunne, Theerasuk Kawamatawong, Peter S. Fenwick, Ceri M. Davies, Hannah Tullett, Peter J. Barnes & Louise E. Donnelly. (2019) Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory Cell and Molecular Biology 60:4, pages 445-453.
Crossref
Crossref
Thomas Southworth, Manminder Kaur, Lynsey Hodgson, Fabrizio Facchinetti, Gino Villetti, Maurizio Civelli & Dave Singh. (2019) Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients. Cytokine 113, pages 68-73.
Crossref
Crossref
Jose Luis Lopez-Campos, Laura Carrasco Hernández, Xavier Muñoz, Víctor Bustamante & Esther Barreiro. (2018) Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level. Respirology 23:9, pages 818-827.
Crossref
Crossref
Øyvind Nicolay Ulland Salvesen, Jesper Rømhild Davidsen, Anton Pottegård & Daniel Pilsgaard Henriksen. (2018) Roflumilast Usage from 2010 to 2016: A Danish Nationwide Drug Utilization Study. Basic & Clinical Pharmacology & Toxicology 123:3, pages 314-319.
Crossref
Crossref
Jiahong Zhong, Hui Yu, Chang Huang, Qiuping Zhong, Yaping Chen, Jinfeng Xie, Zhongzhen Zhou, Jiangping Xu & Haitao Wang. (2018) Inhibition of phosphodiesterase 4 by FCPR16 protects SH-SY5Y cells against MPP+-induced decline of mitochondrial membrane potential and oxidative stress. Redox Biology 16, pages 47-58.
Crossref
Crossref
Ángel Agis-Torres, Paz Recio, María Elvira López-Oliva, María Pilar Martínez, María Victoria Barahona, Sara Benedito, Salvador Bustamante, Miguel Ángel Jiménez-Cidre, Albino García-Sacristán, Dolores Prieto, Vítor S. Fernandes & Medardo Hernández. (2018) Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission. Scientific Reports 8:1.
Crossref
Crossref
V. Pauwelyn, W. Ceelen & R. A. Lefebvre. (2018)
Synergy between 5-HT
4
receptor stimulation and phosphodiesterase 4 inhibition in facilitating acetylcholine release in human large intestinal circular muscle
. Neurogastroenterology & Motility 30:2, pages e13162.
Crossref
Crossref
Joy Creaser-Thomas, Vignesh Rajasundaram & Gwyneth A Davies. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
161
171
.